美國居民不適用 XM 服務。
B
B

BayerAG

交易方向

交易者脈動

技術摘要

小時

財經新聞

Jefferies ups Orion on strong Nubeqa sales

BUZZ-Jefferies ups Orion on strong Nubeqa sales ** Jefferies upgrades Finnish drugmaker Orion ORNBV.HE to "hold" from "underperform" following the recent Nubeqa sales acceleration reported by Bayer BAYGn.DE ** Nubeqa is prostate cancer treatment jointly developed by Orion and Bayer ** Jefferies lifts its estimate for Nubeqa peak sales to 750 millio
B
P

India economic, corporate events on August 14

DIARY- India economic, corporate events on August 14 BENGALURU, Aug 14 (Reuters) - Diary of India economic, corporate events on August 14. ECONOMIC, CORPORATE .BSE500 EVENTS: RIC Local Start Date Local Time Indicator Name Period Reuters Poll Prior INIPSO=ECI 14 Aug 2024 07:30 LSEG IPSOS PCSI Aug 64.52 INWPI=ECI 14 Aug 2024 12:00 WPI Inflation YY Ju
B

India's Heranba Industries set for best-ever day on posting Q1 profit

BUZZ-India's Heranba Industries set for best-ever day on posting Q1 profit ** Shares of Heranba Industries HERN.NS surge 20%, hitting upper circuit, to highest since Jan 2023 ** Stock set for best day since listing on March 2021 ** Agrochemical co posted Q1 profit vs yr-ago loss ** Larger rival UPL UPLL.NS posted wider-than-expected loss , Bayer Cr
B

India's Bayer CropScience falls on Q1 profit drop

BUZZ-India's Bayer CropScience falls on Q1 profit drop ** Shares of Bayer CropScience BAYE.NS fall as much as 8.3% to 6,350 rupees; last down 4.8% ** Pesticide maker reported a near 23% fall in June-quarter profit while rev from ops dropped 6% ** BAYE set for worst session in more than two months ** Avg rating of six analysts covering the stock is
B

Biotech firm Recursion to buy smaller peer Exscientia for $688 million

Biotech firm Recursion to buy smaller peer Exscientia for $688 million By Anirban Sen NEW YORK, Aug 8 (Reuters) - Recursion Pharmaceuticals RXRX.O , a biotech firm which uses artificial intelligence to discover new drug candidates, has agreed to buy smaller rival Exscientia EXAI.O for $688 million in an all-stock deal, according to a statement seen by Reuters.
B
N
R
S

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明